Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Cns Pharmaceuticals Inc
(NQ:
CNSP
)
0.3620
-0.0080 (-2.16%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
182,004
Open
0.3675
Bid (Size)
0.3630 (24)
Ask (Size)
0.3930 (1)
Prev. Close
0.3700
Today's Range
0.3782 - 0.3782
52wk Range
0.2290 - 4.400
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
New Research Sheds Light on the Initial Stages of Brain Cancer Development
March 18, 2024
Via
Investor Brand Network
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Welcomes Proven Commercialization Leader to Its Board of Directors
March 18, 2024
Via
Investor Brand Network
Performance
YTD
-69.58%
-69.58%
1 Month
+40.15%
+40.15%
3 Month
-71.27%
-71.27%
6 Month
-67.09%
-67.09%
1 Year
-63.66%
-63.66%
More News
Read More
Study Shows Troops That Sustain Serious Brain Injuries Have Higher Risk of Brain Cancer
February 26, 2024
Via
Investor Brand Network
Top 5 Health Care Stocks That Are Preparing To Pump In February
February 09, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 07, 2024
Via
Benzinga
Biotech Commercialization Leader, Amy Mahery, to Join CNS Pharmaceuticals Board of Directors
January 18, 2024
Via
ACCESSWIRE
Scientists Start Trialing First Blood Test Against Brain Cancer
February 05, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 30, 2024
Via
Benzinga
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
January 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 30, 2024
Via
Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Releases Information on $4M Public Offering Pricing
January 30, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 30, 2024
Via
Benzinga
Why Super Micro Computer Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
January 30, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
January 30, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
January 29, 2024
Via
Benzinga
CNS Pharmaceuticals Announces Pricing of $4.0 Million Public Offering
January 29, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 24, 2024
Via
Benzinga
Novel Brain Scan Technique Exposes Vulnerability of Gliomas
January 23, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Monday's Intraday Session
January 22, 2024
Via
Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Names Seasoned Biotech Leader to Board of Directors
January 19, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Thursday's After-Market Session
January 18, 2024
Via
Benzinga
BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reaches Planned Enrollment Berubicin Study for the Treatment of GBM
January 18, 2024
Via
Investor Brand Network
Exposures
Product Safety
CNS Pharmaceuticals Achieves Completion of Planned Enrollment in Potentially Pivotal Study of Berubicin for the Treatment of Glioblastoma Multiforme (GBM)
January 17, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 16, 2024
Via
Benzinga
Multidisciplinary Consortium Sets Sights on Developing AI to Detect Gliomas
January 10, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.